Novakand Pharma AB (publ) - Asset Resilience Ratio
Novakand Pharma AB (publ) (LARK) has an Asset Resilience Ratio of 5.73% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. For the complete balance sheet picture, see LARK total assets.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2025–2025)
This chart shows how Novakand Pharma AB (publ)'s Asset Resilience Ratio has changed over time. Read total liabilities of Novakand Pharma AB (publ) for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Novakand Pharma AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. See operational self-sufficiency of Novakand Pharma AB (publ) to measure how many days the company can operate on defensive assets alone.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr3.25 Million | 5.73% |
| Total Liquid Assets | Skr3.25 Million | 5.73% |
Asset Resilience Insights
- Limited Liquidity: Novakand Pharma AB (publ) maintains only 5.73% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Novakand Pharma AB (publ) Industry Peers by Asset Resilience Ratio
Compare Novakand Pharma AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gresham House Energy Storage Fund PLC
LSE:GRID |
Asset Management | 13.08% |
|
Amundi SA
PA:AMUN |
Asset Management | 5.80% |
|
Sprott Physical Gold Trust
TO:PHYS |
Asset Management | 99.63% |
|
Industrivarden AB ser. A
ST:INDU-A |
Asset Management | 0.68% |
|
Caitong Securities Co Ltd
SHG:601108 |
Asset Management | 13.57% |
|
Anxin Trust Co Ltd
SHG:600816 |
Asset Management | 36.21% |
|
Sprott Inc.
TO:SII |
Asset Management | 1.84% |
|
CI Financial Corp
TO:CIX |
Asset Management | 1.81% |
Annual Asset Resilience Ratio for Novakand Pharma AB (publ) (2025–2025)
The table below shows the annual Asset Resilience Ratio data for Novakand Pharma AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.73% | Skr3.25 Million ≈ $349.54K |
Skr56.73 Million ≈ $6.11 Million |
-- |
About Novakand Pharma AB (publ)
Lärkberget AB (publ) operates as an investment company. The company is involved in direct investments in low-risk instruments, and unlisted profitable companies; financial investments; and reverse acquisition business. It also invests in listed shares, funds and other liquid asset classes, as well as participates in bridge loans and guarantee commitments. The company was formerly known as CombiGe… Read more